Cargando…

A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners

Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated that glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Holborough-Kerkvliet, Miles D, Mucignato, Greta, Moons, Sam J, Psomiadou, Venetia, Konada, Rohit S R, Pedowitz, Nichole J, Pratt, Matthew R, Kissel, Theresa, Koeleman, Carolien A M, Tjokrodirijo, Rayman T N, van Veelen, Petrus A, Huizinga, Thomas, van Schie, Karin A J, Wuhrer, Manfred, Kohler, Jennifer J, Bonger, Kimberly M, Boltje, Thomas J, Toes, Reinaldus E M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627247/
https://www.ncbi.nlm.nih.gov/pubmed/37498177
http://dx.doi.org/10.1093/glycob/cwad055
_version_ 1785131499848204288
author Holborough-Kerkvliet, Miles D
Mucignato, Greta
Moons, Sam J
Psomiadou, Venetia
Konada, Rohit S R
Pedowitz, Nichole J
Pratt, Matthew R
Kissel, Theresa
Koeleman, Carolien A M
Tjokrodirijo, Rayman T N
van Veelen, Petrus A
Huizinga, Thomas
van Schie, Karin A J
Wuhrer, Manfred
Kohler, Jennifer J
Bonger, Kimberly M
Boltje, Thomas J
Toes, Reinaldus E M
author_facet Holborough-Kerkvliet, Miles D
Mucignato, Greta
Moons, Sam J
Psomiadou, Venetia
Konada, Rohit S R
Pedowitz, Nichole J
Pratt, Matthew R
Kissel, Theresa
Koeleman, Carolien A M
Tjokrodirijo, Rayman T N
van Veelen, Petrus A
Huizinga, Thomas
van Schie, Karin A J
Wuhrer, Manfred
Kohler, Jennifer J
Bonger, Kimberly M
Boltje, Thomas J
Toes, Reinaldus E M
author_sort Holborough-Kerkvliet, Miles D
collection PubMed
description Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated that glycans expressed by these B-cell-specific molecules can modulate immune activation via glycan-binding proteins. In several autoimmune diseases, an increased prevalence of variable domain glycosylation of IgG autoantibodies has been observed. Especially, the hallmarking autoantibodies in rheumatoid arthritis, anti-citrullinated protein antibodies, carry a substantial amount of variable domain glycans. The variable domain glycans expressed by these autoantibodies are N-linked, complex-type, and α2–6 sialylated, and B-cell receptors carrying variable domain glycans have been hypothesized to promote selection of autoreactive B cells via interactions with glycan-binding proteins. Here, we use the anti-citrullinated protein antibody response as a prototype to study potential in solution and in situ B-cell receptor–variable domain glycan interactors. We employed SiaDAz, a UV-activatable sialic acid analog carrying a diazirine moiety that can form covalent bonds with proximal glycan-binding proteins. We show, using oligosaccharide engineering, that SiaDAz can be readily incorporated into variable domain glycans of both antibodies and B-cell receptors. Our data show that antibody variable domain glycans are able to interact with inhibitory receptor, CD22. Interestingly, although we did not detect this interaction on the cell surface, we captured CD79 β glycan–B-cell receptor interactions. These results show the utility of combining photoaffinity labeling and oligosaccharide engineering for identifying antibody and B-cell receptor interactions and indicate that variable domain glycans appear not to be lectin cis ligands in our tested conditions.
format Online
Article
Text
id pubmed-10627247
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106272472023-11-07 A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners Holborough-Kerkvliet, Miles D Mucignato, Greta Moons, Sam J Psomiadou, Venetia Konada, Rohit S R Pedowitz, Nichole J Pratt, Matthew R Kissel, Theresa Koeleman, Carolien A M Tjokrodirijo, Rayman T N van Veelen, Petrus A Huizinga, Thomas van Schie, Karin A J Wuhrer, Manfred Kohler, Jennifer J Bonger, Kimberly M Boltje, Thomas J Toes, Reinaldus E M Glycobiology Original Article Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated that glycans expressed by these B-cell-specific molecules can modulate immune activation via glycan-binding proteins. In several autoimmune diseases, an increased prevalence of variable domain glycosylation of IgG autoantibodies has been observed. Especially, the hallmarking autoantibodies in rheumatoid arthritis, anti-citrullinated protein antibodies, carry a substantial amount of variable domain glycans. The variable domain glycans expressed by these autoantibodies are N-linked, complex-type, and α2–6 sialylated, and B-cell receptors carrying variable domain glycans have been hypothesized to promote selection of autoreactive B cells via interactions with glycan-binding proteins. Here, we use the anti-citrullinated protein antibody response as a prototype to study potential in solution and in situ B-cell receptor–variable domain glycan interactors. We employed SiaDAz, a UV-activatable sialic acid analog carrying a diazirine moiety that can form covalent bonds with proximal glycan-binding proteins. We show, using oligosaccharide engineering, that SiaDAz can be readily incorporated into variable domain glycans of both antibodies and B-cell receptors. Our data show that antibody variable domain glycans are able to interact with inhibitory receptor, CD22. Interestingly, although we did not detect this interaction on the cell surface, we captured CD79 β glycan–B-cell receptor interactions. These results show the utility of combining photoaffinity labeling and oligosaccharide engineering for identifying antibody and B-cell receptor interactions and indicate that variable domain glycans appear not to be lectin cis ligands in our tested conditions. Oxford University Press 2023-07-27 /pmc/articles/PMC10627247/ /pubmed/37498177 http://dx.doi.org/10.1093/glycob/cwad055 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Holborough-Kerkvliet, Miles D
Mucignato, Greta
Moons, Sam J
Psomiadou, Venetia
Konada, Rohit S R
Pedowitz, Nichole J
Pratt, Matthew R
Kissel, Theresa
Koeleman, Carolien A M
Tjokrodirijo, Rayman T N
van Veelen, Petrus A
Huizinga, Thomas
van Schie, Karin A J
Wuhrer, Manfred
Kohler, Jennifer J
Bonger, Kimberly M
Boltje, Thomas J
Toes, Reinaldus E M
A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
title A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
title_full A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
title_fullStr A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
title_full_unstemmed A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
title_short A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
title_sort photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627247/
https://www.ncbi.nlm.nih.gov/pubmed/37498177
http://dx.doi.org/10.1093/glycob/cwad055
work_keys_str_mv AT holboroughkerkvlietmilesd aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT mucignatogreta aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT moonssamj aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT psomiadouvenetia aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT konadarohitsr aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT pedowitznicholej aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT prattmatthewr aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT kisseltheresa aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT koelemancarolienam aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT tjokrodirijoraymantn aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT vanveelenpetrusa aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT huizingathomas aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT vanschiekarinaj aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT wuhrermanfred aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT kohlerjenniferj aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT bongerkimberlym aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT boltjethomasj aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT toesreinaldusem aphotoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT holboroughkerkvlietmilesd photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT mucignatogreta photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT moonssamj photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT psomiadouvenetia photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT konadarohitsr photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT pedowitznicholej photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT prattmatthewr photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT kisseltheresa photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT koelemancarolienam photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT tjokrodirijoraymantn photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT vanveelenpetrusa photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT huizingathomas photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT vanschiekarinaj photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT wuhrermanfred photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT kohlerjenniferj photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT bongerkimberlym photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT boltjethomasj photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners
AT toesreinaldusem photoaffinityglycanlabelingapproachtoinvestigateimmunoglobulinglycanbindingpartners